Enterococci. Biologic and epidemiologic characteristics and in vitro susceptibility
- 25 October 1982
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 142 (11) , 2006-2009
- https://doi.org/10.1001/archinte.142.11.2006
Abstract
Enterococci cause urinary tract infection (usually asymptomatic), 5-15% of [human] cases of endocarditis and rare cases of meningitis. Their role in polymicrobial infection in the abdomen and pelvis is difficult to assess. Ninety percent of enterococci are inhibited by 4 mg/l of penicillin G, by 2 mg/l of ampicillin and by 6 mg/l of vancomycin. The penicillinase-resistant penicillins, cephalosporins, carbenicillin and ticarcillin are at least 4-fold less active against enterococci than penicillin g; piperacillin has activity equivalent to penicillin G. The addition of an aminoglycoside to penicillin, ampicillin, vancomycin or piperacillin, which are not bactericidal against most strains of enterococci, results in more rapid and complete bactericidal activity (i.e., synergistic activity).This publication has 6 references indexed in Scilit:
- Enterococcal Superinfection and Colonization After Therapy with Moxalactam, a New Broad-Spectrum AntibioticAnnals of Internal Medicine, 1981
- Comparative In Vitro Appraisal of Piperacillin, Including Its Activity Against Salmonella typhiAntimicrobial Agents and Chemotherapy, 1980
- Comparative Evaluation of Piperacillin in VitroAntimicrobial Agents and Chemotherapy, 1978
- Plasmid-Mediated Mechanisms of Resistance to Aminoglycoside-Aminocyclitol Antibiotics and to Chloramphenicol in Group D StreptococciAntimicrobial Agents and Chemotherapy, 1978
- Clindamycin in the Treatment of Serious Anaerobic InfectionsAnnals of Internal Medicine, 1973
- Changing Patterns of Susceptibility of Common Bacterial Pathogens to Antimicrobial AgentsAnnals of Internal Medicine, 1972